Amgen net edges higher on anemia, arthritis drugs - MarketWatch
January 25, 2007| Amgen net edges higher on anemia, arthritis drugs MarketWatch - Sales of the rheumatoid-arthritis treatment Enbrel, which Amgen sells in North America, came in at $792 million in the latest quarter vs. ... |
First Actemra multinational phase III trial demonstrates ... - PipelineReview.com (press release)
January 25, 2007| First Actemra multinational phase III trial demonstrates ... PipelineReview.com (press release), Spain - Actemra, through its unique blockade of the interleukin-6 receptor, will provide a new treatment option for people afflicted by rheumatoid arthritis," ... Phase III ACTEMRA(TM) (tocilizumab) Study Results Demonstrate ... |
Steroids Boost Joint Health in RA - Ivanhoe
January 25, 2007| Steroids Boost Joint Health in RA Ivanhoe, FL - Researchers who looked at 15 clinical trials conclude adding steroid therapy to standard rheumatoid arthritis drugs in the first two years after diagnosis ... |
Phase III ACTEMRA(TM) (tocilizumab) Study Results Demonstrate ... - Medical News Today (press release)
January 25, 2007| Phase III ACTEMRA(TM) (tocilizumab) Study Results Demonstrate ... Medical News Today (press release), UK - Rheumatoid arthritis is a progressive, systemic autoimmune disease characterized by inflammation of the membrane lining in the joints. ... |